Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works—just days before regulators debate whether to offer Americans updated booster shots this fall.
Jun 25, 2022
2
244
There is now a second COVID-19 option for kids ages 6 to 17 in the U.S.
Jun 24, 2022
0
10
An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17 Thursday.
Jun 24, 2022
0
10
A study that tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people. The findings by scientists from The University of Manchester and published as a research ...
Jun 22, 2022
0
4
The U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers.
Jun 18, 2022
0
25
A U.S. Food and Drug Administration vaccine advisory panel will weigh whether to recommend the emergency use of Novavax's COVID-19 vaccine on Tuesday.
Jun 7, 2022
0
5
US drugs giant Pfizer will exit its consumer healthcare joint venture with GlaxoSmithKline after the unit is spun off next month, the British drugmaker said Wednesday.
Jun 1, 2022
0
1
Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world's poorest countries.
May 25, 2022
0
1
The head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries, saying Tuesday that the pharmaceutical company's deal allowing generic producers to make ...
May 10, 2022
0
7
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own.
May 10, 2022
0
0
